RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24533711http://www.w3.org/2000/01/rdf-schema#comment"

Aim

HLA-B*57:01 status needs to be determined before initiating abacavir therapy. We developed a pharmacogenetic real-time (Q)-PCR screening test using two sets of sequence specific primers. This test has been implemented into routine clinical practice.

Materials & methods

HIV-infected patients admitted at our University Hospital were thus genotyped using the above mentioned test. A panel of 80 DNA samples with a known genotype were used to characterize Q-PCR conditions using different master mixes.

Results

A total of 353 patients were genotyped, detecting 15 (4.25%) HLA-B*57:01 positive carriers. Among the negative patients, 17.2% were treated with abacavir without any hypersensitivity reaction. Using different Q-PCR master mixes, significantly lower cutoff Ct values were found, thus new analytical settings are provided.

Conclusion

The pharmacogenetic test developed in our laboratory for the fast screening of HLA-B*57:01 can be successfully implemented into routine clinical practice. All 16 sequences (including an additional six) currently known for the HLA-B*57:01 allele are detected by sequence specific primers used in this test. The Brilliant II SYBR(®) Green QPCR MM (Stratagene) can safely replace the master mix originally used to develop the test."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.org/dc/terms/identifier"doi:10.2217/pgs.13.242"xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Gagliardi D."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Cauda R."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Fabbiani M."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Di Giambenedetto S."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Navarra P."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Dello Russo C."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Lisi L."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/author"Fanti I."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/name"Pharmacogenomics"xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/pages"319-327"xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/title"Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data."xsd:string
http://purl.uniprot.org/citations/24533711http://purl.uniprot.org/core/volume"15"xsd:string
http://purl.uniprot.org/citations/24533711http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24533711
http://purl.uniprot.org/citations/24533711http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24533711
http://purl.uniprot.org/uniprot/#_A0A0A7C552-mappedCitation-24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24533711
http://purl.uniprot.org/uniprot/#_A0A0E3DC98-mappedCitation-24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24533711
http://purl.uniprot.org/uniprot/#_A0A0E3DCA0-mappedCitation-24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24533711
http://purl.uniprot.org/uniprot/#_A0A0E3DCA1-mappedCitation-24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24533711
http://purl.uniprot.org/uniprot/#_A0A068B107-mappedCitation-24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24533711
http://purl.uniprot.org/uniprot/#_A0A068B112-mappedCitation-24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24533711
http://purl.uniprot.org/uniprot/#_A0A068B116-mappedCitation-24533711http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24533711